Trial intelligence / Profile preview

BAR monitor during fentanyl dosing in coronary artery bypass surgery

ACTRN12611000978965Phase 4Completed

Sponsor
Cortical Dynamics
Start
Dec 2011
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of fentanyl (2 arms), sponsored by Cortical Dynamics. Primary endpoint: BAR monitor ability to detect varying anesthetic levels. Started Dec 2011; status: completed.

02

Drugs

fentanyl

Beyond the preview

Go deeper on ACTRN12611000978965.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12611000978965.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call